BAGSVAERD, DENMARK--(Marketwire - March 18, 2013) - Company Announcement No 20 2013: http://hugin.info/2013/R/1686007/552562.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
[HUG#1686007]
Further information:
Media:
Anne Margrethe Hauge
Tel: +45 4442 3450
Email Contact
Ken Inchausti (US)
Tel: +1 609 514 8316
Email Contact
Investors:
Kasper Roseeuw Poulsen
Tel: +45 4442 4303
Email Contact
Frank Daniel Mersebach
Tel: +45 4442 0604
Email Contact
Lars Borup Jacobsen
Tel: +45 3075 3479
Email Contact
Jannick Lindegaard (US)
Tel: +1 609 786 4575
Email Contact